Cord blood therapy offers hope for long COVID sufferers
NCT ID NCT07332338
First seen Jan 12, 2026 · Last updated May 08, 2026 · Updated 17 times
Summary
This expanded access program offers REGENECYTE, a human umbilical cord blood infusion, to adults with Long COVID who are not eligible for other clinical trials. The goal is to manage ongoing symptoms like chronic fatigue. Participants must have a recent negative COVID-19 test and provide consent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
D&H National Research Center #1
AVAILABLEMiami, Florida, 33169, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Myrak Research Center Inc.
AVAILABLEMiami Lakes, Florida, 33014, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.